Navigating Poststroke Antithrombotic Therapy Guidelines for Optimal Patient Outcomes

Stroke is a growing health concern in the United States. Effective secondary prevention through antithrombotic pharmacological agents is crucial yet understanding and adherence to guidelines among nurses can be challenging, impacting patient care. This article aims to enhance nurses' understanding of antithrombotic therapy guidelines for secondary stroke prevention, as outlined in the 2021 American Heart Association (AHA)/American Stroke Association (ASA) guidelines.

Review of literature summarizes the updated 2021 AHA/ASA antithrombotic therapy guidelines for treatment and secondary prevention, using visual aids to illustrate antithrombotic therapy algorithms and pharmacological review.

The evidence-based pharmacological review is expected to significantly enhance nurses' understanding of the 2021 AHA/ASA antithrombotic therapy guidelines for secondary stroke prevention and associated clinical drug trials. This comprehensive review aims to foster informed clinical decision-making and provider-patient education.

By summarizing complex pharmacological guidelines, this article aims to empower nurses with the knowledge and tools necessary for effective decision-making and patient education in poststroke antithrombotic treatment. Enhanced understanding and adherence to these guidelines can significantly impact patient outcomes, reducing stroke-related morbidity and mortality. This educational initiative underscores the critical role rehabilitation nurses have in optimizing secondary stroke prevention and improving overall patient care.